Fundraising Fox
/People
Sign in

Nancy Hong

Board director at SeQure Dx · Director at Xilio Therapeutics · Director at Bluejaytx · Former Managing Director at RiverVest Venture Partners

San Diego, California

Writes $100K – $10M checks · typically $1M

Find your path to Nancy

51 people in our graph can introduce you to Nancy.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Ellen E. Sheets to introduce you to Nancy

You →Ellen · together at SeQure Dx (2021–2023) →Nancy

Ask Jamie Chen to introduce you to Nancy

You →Jamie · 6 people · together at Genomics Institute of the Novartis Research Foundation →Nancy

Ask Sam Okafor to introduce you to Nancy

You →Sam · 2 people · together at Xilio Therapeutics →Nancy

Sign up to find every way you can get introduced to Nancy

  • Your email: the people you already email who know Nancy
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Nancy
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Nancy Hong is a lifescience investor with technical background and operating experience. She has held both GP and LP investing roles and serves as a Board Member at the San Diego Symphony.

Board director at SeQure Dx

Intro paths

→

In turn, Nancy can intro founders to SeQure Dx's investors below.

SeQure Dx's investors · 4

Bold Capital PartnersSanta MonicaDigitalis VenturesNew York · $100K – $10M checksKdT VenturesAustin · $500K – $3M checksRiverVest Venture PartnersSt. Louis · $500K – $3M checks

Director at Xilio Therapeutics

Intro paths

→

In turn, Nancy can intro founders to Xilio Therapeutics's investors below.

Xilio Therapeutics's investors · 16

AbingworthLondon · $15M – $30M checks · since 2020Atlas VentureCambridge · $500K – $1M checks · since 2021Bain CapitalBoston · since 2021Bain Capital Life SciencesBoston · since 2021Bay City CapitalSan Rafael · $5M – $10M checksDeerfield Management CompanyNew YorkF-Prime CapitalCambridge · $3M – $10M checks · since 2021M VenturesLos Angeles · $10.8M checks · since 2020MRL Ventures FundCambridge · $25M checksRA CapitalBostonRiverVest Venture PartnersSt. Louis · $500K – $3M checksRock Springs CapitalBaltimoreSolasta VenturesBostonSV Health InvestorsLondon · $1M – $20M checks · since 2018SV7 Impact MedicineLondonTakeda VenturesCambridge · $1M – $5M checks

Co-founders at Xilio Therapeutics

RRRené Russo
René RussoExecutive Officer, Director

Director at Bluejaytx

Intro paths

→

In turn, Nancy can intro founders to Bluejaytx's investors below.

Bluejaytx's investors · 9

Frazier Healthcare PartnersSeattle · $50M – $400M checks · since 2024Frazier Life SciencesPalo Alto · since 2024HBM Healthcare InvestmentsZug · since 2024Novo HoldingsCopenhagen · $1.1M – $54M checks · since 2024RA CapitalBoston · since 2024RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2024T. Rowe PriceBaltimore · since 2024Unicorn Capital Partnerssince 2024Wellington ManagementBoston · $5M – $50M checks · since 2024

Co-founders at Bluejaytx

KCKeting Chu
Keting ChuFounder, Chief Executive Officer and Chairman of the Board

Experience

  1. San Diego SymphonyBoard Membercurrent2021 — present
  2. BiolinqBoard Member2021 — 2023San Diego, California, United States
  3. Bluejay TherapeuticsBoard Member2021 — 2023San Francisco Bay Area
  4. SeQure DxBoard Member2021 — 2023Waltham, Massachusetts, United States
  5. Scout BioBoard Member2019 — 2023Philadelphia, Pennsylvania, United States
  6. RiverVest Venture PartnersManaging Director2016 — 2023Greater San Diego Area
  7. Xilio Therapeutics, Inc.Board Member and Observer2019 — 2021Waltham, Massachusetts, United States
  8. BioMed RealtyPrincipal at BioMed Ventures2015 — 2016Greater San Diego Area
  9. BioMed RealtySenior Associate at BioMed Ventures2013 — 2015Greater San Diego Area
  10. IndependentBiotech Consultant2010 — 2013
  11. Genomics Institute of the Novartis Research FoundationScientist2009Greater San Diego Area
  12. Forward VenturesSenior Analyst2007 — 2008Greater San Diego Area
  13. Biology consultant2006 — 2007
  14. Phenomix CorporationSenior Scientist2002 — 2006Greater San Diego Area

Skills & more

Biotechnology15Bioinformatics3Lifesciences2Drug Discovery2Molecular Biology6Genomics4Drug Development3Oncology6Clinical Development1Immunology6Pharmaceutical Industry2Technology Transfer2
+6 moreBiochemistryCommercializationVenture CapitalCell BiologyLife SciencesBiopharmaceuticals

From Nancy's professional profile.

Frequently asked questions

Who is Nancy Hong?
Nancy Hong is a lifescience investor with technical background and operating experience. She has held both GP and LP investing roles and serves as a Board Member at the San Diego Symphony.
Where does Nancy Hong work?
Nancy Hong is Board director at SeQure Dx.
What check size does Nancy Hong write?
Nancy Hong typically writes checks of $100K – $10M.
Where did Nancy Hong go to school?
Nancy Hong studied at Caltech (B.S., Biology); University of California, Berkeley (Ph.D., Molecular and Cellular Biology); University of California, San Francisco (Postdoc, Biology).

Same school

Shared employers